These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30681660)

  • 1. Antiviral drugs for treatment and prophylaxis of seasonal influenza.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):1-4. PubMed ID: 30681660
    [No Abstract]   [Full Text] [Related]  

  • 2. Expanded table: Antiviral drugs for treatment and prophylaxis of seasonal influenza 2018-2019.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):e11-e12. PubMed ID: 30681664
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2020 Jan; 62(1589):1-4. PubMed ID: 31999661
    [No Abstract]   [Full Text] [Related]  

  • 4. Baloxavir marboxil (Xofluza) for treatment of influenza.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral drugs for influenza for 2020-2021.
    Med Lett Drugs Ther; 2020 Nov; 62(1610):169-172. PubMed ID: 33429402
    [No Abstract]   [Full Text] [Related]  

  • 6. Expanded table: antiviral drugs for influenza (online only).
    Med Lett Drugs Ther; 2020 Jan; 62(1589):e9-e10. PubMed ID: 31999664
    [No Abstract]   [Full Text] [Related]  

  • 7. Expanded table: Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2020 Nov; 62(1610):e2-e4. PubMed ID: 33429406
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral drugs for influenza for 2022-2023.
    Med Lett Drugs Ther; 2022 Nov; 64(1664):185-190. PubMed ID: 36397189
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison chart: Antiviral drugs for influenza for 2022-2023.
    Med Lett Drugs Ther; 2022 Nov; 64(1664):e1-e5. PubMed ID: 36397192
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiviral drugs for seasonal influenza 2017-2018.
    Med Lett Drugs Ther; 2018 Jan; 60(1537):1-4. PubMed ID: 29294462
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral drugs for influenza for 2023-2024.
    Med Lett Drugs Ther; 2023 Nov; 65(1689):177-182. PubMed ID: 37935018
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison chart: Antiviral drugs for influenza for 2023-2024.
    Med Lett Drugs Ther; 2023 Nov; 65(1689):e1-e6. PubMed ID: 37935021
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza vaccine for 2023-2024.
    Med Lett Drugs Ther; 2023 Oct; 65(1687):161-166. PubMed ID: 37871115
    [No Abstract]   [Full Text] [Related]  

  • 14. Influenza vaccine for 2022-2023.
    Med Lett Drugs Ther; 2022 Oct; 64(1660):153-157. PubMed ID: 36206165
    [No Abstract]   [Full Text] [Related]  

  • 15. Baloxavir (Xofluza) for post-exposure prophylaxis of influenza.
    Med Lett Drugs Ther; 2021 Jan; 63(1615):2-3. PubMed ID: 33646997
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral drugs for seasonal influenza 2015-2016.
    Med Lett Drugs Ther; 2015 Dec; 57(1484):169-71. PubMed ID: 26670552
    [No Abstract]   [Full Text] [Related]  

  • 17. Baloxavir marboxil: the new influenza drug on the market.
    O'Hanlon R; Shaw ML
    Curr Opin Virol; 2019 Apr; 35():14-18. PubMed ID: 30852344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccine for 2021-2022.
    Med Lett Drugs Ther; 2021 Oct; 63(1634):153-157. PubMed ID: 34550956
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.
    Muñoz FM; Anderson EJ; Deville JG; Clinch B; Kamal MA
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):531-40. PubMed ID: 26042486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.